Skip to main content

IMPACTO DE LA REPROGRAMACION METABOLICA DE LOS ASTROCITOS SOBRE LA FUNCION NEURONAL IN VIVO EN SALUD Y ENFERMEDAD

PID2019-105699RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 25
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

l-Serine links metabolism with neurotransmission

  • Maugard, Marianne
  • Vigneron, Pierre-Antoine
  • Bolaños, Juan P.
  • Bonvento, Gilles
Brain energy metabolism is often considered as a succession of biochemical steps that metabolize the fuel (glucose and oxygen) for the unique purpose of providing sufficient ATP to maintain the huge information processing power of the brain. However, a significant fraction (10–15 %) of glucose is shunted away from the ATP-producing pathway (oxidative phosphorylation) and may be used to support other functions. Recent studies have pointed to the marked compartmentation of energy metabolic pathways between neurons and glial cells. Here, we focused our attention on the biosynthesis of l-serine, a non-essential amino acid that is formed exclusively in glial cells (mostly astrocytes) by re-routing the metabolic fate of the glycolytic intermediate, 3-phosphoglycerate (3PG). This metabolic pathway is called the phosphorylated pathway and transforms 3PG into l-serine via three enzymatic reactions. We first compiled the available data on the mechanisms that regulate the flux through this metabolic pathway. We then reviewed the current evidence that is beginning to unravel the roles of l-serine both in the healthy and diseased brain, leading to the notion that this specific metabolic pathway connects glial metabolism with synaptic activity and plasticity. We finally suggest that restoring astrocyte-mediated l-serine homeostasis may provide new therapeutic strategies for brain disorders., This work was supported by grants from the Agence Nationale de la Recherche (ANR 2011MALZ-0003 to GB), Association France Alzheimer and Fondation de France (Prix Spécial 2012 to GB), Fondation Plan Alzheimer (GB), Infrastructure de Recherche translationnelle pour les Biothérapies en Neurosciences-NeurATRIS ANR-11-INBS-0011 (GB). PAV is a recipient of a PhD fellowship from the Fondation pour la Recherche Médicale (FRM grant number ECO20170637547). Juan P. Bolanos is funded by MCINU (PID2019-105699RB-I00/ AEI / 10.13039/501100011033 and RED2018-102576-T), Instituto de Salud Carlos III (RD12/0043/0021), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, and Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2–p53 Pathway

  • Barrio, Emilia
  • Vecino, Rebeca
  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Suarez-Pindado, Alberto
  • Bolaños, Juan P.
  • Almeida, Angeles
  • Delgado-Esteban, María
One of the most important mechanisms of preconditioning-mediated neuroprotection is the attenuation of cell apoptosis, inducing brain tolerance after a subsequent injurious ischemia. In this context, the antiapoptotic PI3K/AKT signaling pathway plays a key role by regulating cell differentiation and survival. Active AKT is known to increase the expression of murine double minute-2 (MDM2), an E3-ubiquitin ligase that destabilizes p53 to promote the survival of cancer cells. In neurons, we recently showed that the MDM2–p53 interaction is potentiated by pharmacological preconditioning, based on subtoxic stimulation of NMDA glutamate receptor, which prevents ischemia-induced neuronal apoptosis. However, whether this mechanism contributes to the neuronal tolerance during ischemic preconditioning (IPC) is unknown. Here, we show that IPC induced PI3K-mediated phosphorylation of AKT at Ser473, which in turn phosphorylated MDM2 at Ser166. This phosphorylation triggered the nuclear stabilization of MDM2, leading to p53 destabilization, thus preventing neuronal apoptosis upon an ischemic insult. Inhibition of the PI3K/AKT pathway with wortmannin or by AKT silencing induced the accumulation of cytosolic MDM2, abrogating IPC-induced neuroprotection. Thus, IPC enhances the activation of PI3K/AKT signaling pathway and promotes neuronal tolerance by controlling the MDM2–p53 interaction. Our findings provide a new mechanistic pathway involved in IPC-induced neuroprotection via modulation of AKT signaling, suggesting that AKT is a potential therapeutic target against ischemic injury., This research was funded by the Instituto de Salud Carlos III (PI18/00103 to M.D.-E.; PI18/00285 and RD16/0019/0018 to A.A.; CB16/10/00282 to J.P.B.), MICINN (PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T to J.P.B.; SAF2017-90794-REDT to A.A.), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03; CSI151P20), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.), Fundación Ramón Areces (to A.A.P. and J.P.B.), European Regional Development Fund, and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009 to A.A.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype

  • Soldati, Chiara
  • López-Fabuel, Irene
  • Wanderlingh, Luca G
  • García-Macia, Marina
  • Monfregola, Jlenia
  • Esposito, Alessandra
  • Napolitano, Gennaro
  • Guevara-Ferrer, Marta
  • Scotto Rosato, Anna
  • Krogsaeter, Einar K.
  • Paquet, Dominik
  • Grimm, Christian
  • Montefusco, Sandro
  • Braulke, Thomas
  • Storch, Stephan
  • Mole, Sara E
  • De Matteis, Maria A.
  • Ballabio, Andrea
  • Sampaio, Julio L
  • McKay, Tristan R.
  • Johannes, Ludger
  • Bolaños, Juan P.
  • Medina, Diego L.
Batten diseases (BDs) are a group of lysosomal storage disorders characterized by seizure, visual loss, and cognitive and motor deterioration. We discovered increased levels of globotriaosylceramide (Gb3) in cellular and murine models of CLN3 and CLN7 diseases and used fluorescent-conjugated bacterial toxins to label Gb3 to develop a cell-based high content imaging (HCI) screening assay for the repurposing of FDA-approved compounds able to reduce this accumulation within BD cells. We found that tamoxifen reduced the lysosomal accumulation of Gb3 in CLN3 and CLN7 cell models, including neuronal progenitor cells (NPCs) from CLN7 patient-derived induced pluripotent stem cells (iPSC). Here, tamoxifen exerts its action through a mechanism that involves activation of the transcription factor EB (TFEB), a master gene of lysosomal function and autophagy. In vivo administration of tamoxifen to the CLN7Δex2 mouse model reduced the accumulation of Gb3 and SCMAS, decreased neuroinflammation, and improved motor coordination. These data strongly suggest that tamoxifen may be a suitable drug to treat some types of Batten disease., This work was funded by the European Union’s Horizon 2020 research and innovation programme (BATCure, grant No. 666918 to DLM, JPB, SEM, TB and SS). JPB is funded by the Agencia Estatal de Investigación (PID2019-105699RB-I00/ AEI / 10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces. SS was funded by a grant from the Mila’s Miracle Foundation. TB was supported by German Research Council (DFG) grant FOR2625. SM benefits from MRC funding to the MRC Laboratory for Molecular Cell Biology University Unit at UCL (award code MC_U12266B) towards laboratory and office space. We acknowledge Marcella Cesana for providing the TFEB virus. Graphical abstract was created using BioRender.com.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis

  • García-Macia, Marina
  • Santos-Ledo, Adrián
  • Leslie, Jack
  • Paish, Hannah L.
  • Collins, Amy L.
  • Scott, Rebecca S.
  • Watson, Abigail
  • Burgoyne, Rachel A.
  • White, Steven A.
  • French, Jeremy
  • Hammond, John
  • Borthwick, Lee A.
  • Mann, Jelena
  • Bolaños, Juan P.
  • Korolchuk, Viktor I.
  • Oakley, Fiona
  • Mann, Derek A.
[Background and Aims] NAFLD is the most common hepatic pathology in western countries and no treatment is currently available. NAFLD is characterized by the aberrant hepatocellular accumulation of fatty acids in the form of lipid droplets (LDs). Recently, it was shown that liver LD degradation occurs through a process termed lipophagy, a form of autophagy. However, the molecular mechanisms governing liver lipophagy are elusive. Here, we aimed to ascertain the key molecular players that regulate hepatic lipophagy and their importance in NAFLD., [Approach and Results] We analyzed the formation and degradation of LD in vitro (fibroblasts and primary mouse hepatocytes), in vivo and ex vivo (mouse and human liver slices) and focused on the role of the autophagy master regulator mammalian target of rapamycin complex (mTORC) 1 and the LD coating protein perilipin (Plin) 3 in these processes. We show that the autophagy machinery is recruited to the LD on hepatic overload of oleic acid in all experimental settings. This led to activation of lipophagy, a process that was abolished by Plin3 knockdown using RNA interference. Furthermore, Plin3 directly interacted with the autophagy proteins focal adhesion interaction protein 200 KDa and autophagy-related 16L, suggesting that Plin3 functions as a docking protein or is involved in autophagosome formation to activate lipophagy. Finally, we show that mTORC1 phosphorylated Plin3 to promote LD degradation., [Conclusions] These results reveal that mTORC1 regulates liver lipophagy through a mechanism dependent on Plin3 phosphorylation. We propose that stimulating this pathway can enhance lipophagy in hepatocytes to help protect the liver from lipid-mediated toxicity, thus offering a therapeutic strategy in NAFLD., Supported by C0120R3166, C0245R4032, and BH182173 from Newcastle University. M. G.-M. is a Sara Borrell Postdoctoral fellow (CD18/00203) from the Ministerio de Ciencia, Innovación y Universidades (Spain). J. P. B. is funded by the Agencia Estatal de Investigación, grants PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T, Instituto de Salud Carlos III (CB16/10/00282), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, and Fundación Ramón Areces. V. I. K. acknowledges support from Biotechnology and Biological Sciences Research Council (BB/M023389/1, BB/R008167/1, BB, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Aberrant upregulation of glycolysis mediates CLN7 neuronal ceroid lipofuscinosis

  • García-Macia, Marina
  • López-Fabuel, Irene
  • Buondelmonte, Constantina
  • Burmistrova, Olga
  • Bonora, Nicoló
  • Morant Ferrando, Brenda
  • Alonso-Batán, Paula
  • Vicente-Gutiérrez, Carlos
  • Jimenez-Blasco, Daniel
  • Quintana-Cabrera, Ruben
  • Fernández, Emilio
  • McKay, Tristan R.
  • Storch, Stephan
  • Medina, Diego L.
  • Mole, Sara E
  • Fedichev, Peter O.
  • Almeida, Angeles
  • Bolaños, Juan P.
Resumen del trabajo presentado en el 43rd Annual Meeting of the Spanish Society of Biochemistry & Molecular Biology, celebrado en Barcelona, del 19 al 22 de julio de 2021, CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. CLN7/MFSD8 gene encodes a lysosomal membrane glycoprotein, but the biochemical processes affected by CLN7-loss of function are unexplored thus preventing development of potential treatments. Here, we found, in the Cln7∆ex2 mouse model of CLN7 disease, that failure in the autophagy-lysosomal pathway causes accumulation of structurally and bioenergetically impaired neuronal mi- tochondria. In vivo genetic approach revealed elevated mitochondrial reactive oxygen species (mROS) in Cln7∆ex2 neurons that mediates glycolysis activation and contributes to CLN7 pathogenesis. Mechanistically, mROS sustains a signaling cascade leading to protein stabilization of PFK- FB3, a glycolytic-promoting enzyme normally unstable in healthy neurons. Pharmacological inhibition of PFKFB3 in Cln7∆ex2 mouse brain in vivo and in CLN7 patients-derived cells rectified key disease hallmarks. Thus, aberrant upregulation of neuronal glycolysis contributes to CLN7 patho-genesis and targeting PFKFB3 may alleviate this and other lysosomal storage diseases, This work was funded by Agencia Estatal de Investigación (PID2019-105699RB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Bates, Georgina
  • Murphy, Michael P.
  • Almeida, Angeles
  • Bolaños, Juan P.
Cells naturally produce mitochondrial reactive oxygen species (mROS), but the in vivo pathophysiological significance has long remained controversial. Within the brain, astrocyte-derived mROS physiologically regulate behaviour and are produced at one order of magnitude faster than in neurons. However, whether neuronal mROS abundance differentially impacts on behaviour is unknown. To address this, we engineered genetically modified mice to down modulate mROS levels in neurons in vivo. Whilst no alterations in motor coordination were observed by down modulating mROS in neurons under healthy conditions, it prevented the motor dis- coordination caused by the pro-oxidant neurotoxin, 3-nitropropionic acid (3-NP). In contrast, abrogation of mROS in astrocytes showed no beneficial effect against the 3-NP insult. These data indicate that the impact of modifying mROS production on mouse behaviour critically depends on the specific cell-type where they are generated., J.P.B. is funded by the Agencia Estatal de Investigación (SAF2016-78114-R, PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), ISCIII (CB16/10/00282), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Bio-medicina 2017 Fundación BBVA and Fundación Ramón Areces. A.A. is unded by the ISCIII (PI18/00265, RD16/0019/0018), AEI (PI18/00265, RD16/0019/0018) and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009). J.P.B. and A.A. are fundedby the grant CSI151P20 from the Junta de Castilla y Leon., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Impact of fatty acids on astrocytic bioenergetics

  • Morant Ferrando, Brenda
  • García-Macia, Marina
  • Jimenez-Blasco, Daniel
  • Fernández, Emilio
  • Carmeliet, Peter
  • Almeida, Angeles
  • Bolaños, Juan P.
Resumen del trabajo presentado en el 43rd Annual Meeting of the Spanish Society of Biochemistry & Molecular Biology, celebrado en Barcelona, del 19 al 22 de julio de 2021, Brain fatty acids metabolism remains underexplored. Recent reports have suggested that astrocytes may utilize fatty acids (1). However, whether acetyl-CoA metabolic fate is the tricarboxylic acid (TCA) cycle to obtain energy, the biosynthesis of ketone bodies, or both metabolic pathways, have not been yet fully deciphered yet (2,3). Besides this, astrocytes contribute to neuronal energy metabolism by shuttling to neurons metabolic glucose-derived precursors, such as lactate (4). However, it is unknown whether neurons utilize astrocytic-generated ketone bodies as energy precursors to maintain neurotransmission (5,6). Here, we aimed to address this issue using a mouse genetic model unable to perform ß-oxidation, specifically in astrocytes.We used a carnitine palmitoyltransferase-1A (CPT1A) gene floxed mouse model to elaborate cortical astrocyte cultures (7). Then, we infected them with adeno-associated viruses (AAVs) that express Cre recombinase (CMV-Cre-GFP) or not (CMV-GFP) to obtain CPT1a-KO and WT astrocytes, respectively. To test whether astrocytes use fatty acids as a mitochondrial fuel, we treated CPT1a-KO and WT astrocytes with oleic acid (250 μM) for 24 hours and measured the rate of oxygen consumption (OCR) using the Seahorse technology. Our results show that oleic acid treatment increases basal respiration and ATP-linked oxygen consumption in WT, but not in CPT1a-KO astrocytes. These changes were not ascribed to possible changes in the mitochondrial population according to citrate synthase activity and TOMM20 expression levels. These results indicate that astrocytes can oxidize fatty acids to produce energy, although further studies need to be performed to decipher if astrocytes are able to synthesize ketone bodies. Ongoing work is being developed to validate these observations in vivo, This work was funded by Agencia Estatal de Investigación (PID2019-105699RB-I00).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

p38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1

  • Santamans, Ayelén M.
  • Montalvo-Romeral, Valle
  • Mora, Alfonso
  • Lopez, Juan Antonio
  • Gonzalez-Romero, Francisco
  • Jimenez-Blasco, Daniel
  • Rodríguez, Elena
  • Pintor-Chocano, Aránzazu
  • Casanueva-Benítez, Cristina
  • Acín-Pérez, Rebeca
  • Leiva-Vega, Luis
  • Duran, Joan
  • Guinovart, Joan J.
  • Jiménez-Borreguero, Jesús
  • Enríquez, José Antonio
  • Villlalba-Orero, María
  • Bolaños, Juan P.
  • Aspichueta, Patricia
  • Vázquez, Jesús
  • González-Terán, Bárbara
  • Sabio, Guadalupe
During the first weeks of postnatal heart development, cardiomyocytes undergo a major adaptive metabolic shift from glycolytic energy production to fatty acid oxidation. This metabolic change is contemporaneous to the up-regulation and activation of the p38γ and p38δ stress-activated protein kinases in the heart. We demonstrate that p38γ/δ contribute to the early postnatal cardiac metabolic switch through inhibitory phosphorylation of glycogen synthase 1 (GYS1) and glycogen metabolism inactivation. Premature induction of p38γ/δ activation in cardiomyocytes of newborn mice results in an early GYS1 phosphorylation and inhibition of cardiac glycogen production, triggering an early metabolic shift that induces a deficit in cardiomyocyte fuel supply, leading to whole-body metabolic deregulation and maladaptive cardiac pathogenesis. Notably, the adverse effects of forced premature cardiac p38γ/δ activation in neonate mice are prevented by maternal diet supplementation of fatty acids during pregnancy and lactation. These results suggest that diet interventions have a potential for treating human cardiac genetic diseases that affect heart metabolism., G.S. is a YIP EMBO member. B.G.T. was a fellow of the FPI Severo Ochoa CNIC program (SVP-2013-067639) and currently is funded by the AHA-CHF (AHA award number: 818798). V.M.R. is a FPI fellow (BES-2014-069332) and A.M.S. is a fellow of the FPI Severo Ochoa CNIC program (BES-2016-077635). This work was funded by the following grants: to G.S.: funding from the EFSD/Lilly European Diabetes Research Programme Dr Sabio, from Spanish Ministry of Science, Innovation and Universities (MINECO-FEDER SAF2016-79126-R and PID2019-104399RB-I00), Comunidad de Madrid (IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-3733) and Fundación Jesús Serra; to P.A.: Ayudas para apoyar grupos de investigación del sistema Universitario Vasco (IT971-16 to P.A.), MCIU/AEI/FEDER, funding from Spanish Ministry of Science, Innovation and Universities (RTI2018-095134-B-100); Excellence Network Grant from MICIU/AEI (SAF2016-81975-REDT and 2018-PN188) to PA and GS; to J.V.: funding from Spanish Ministry of Science, Innovation and Universities (PGC2018-097019-B-I00), the Instituto de Salud Carlos III (Fondo de Investigación Sanitaria grant PRB3 (PT17/0019/0003- ISCIII-SGEFI / ERDF, ProteoRed), and “la Caixa” Banking Foundation (project code HR17-00247); to J.P.B.: funding from Spanish Ministry of Science, Innovation and Universities (PID2019-105699RB-I00, RED2018‐102576‐T) and Escalera de Excelencia (CLU-2017-03); to J.A.E.: funding from Spanish Ministry of Science, Innovation and Universities MINECO (RED2018-102576-T, RTI2018-099357-B-I00), CIBERFES (CB16/10/00282), and HFSP (RGP0016/2018). RAP (XPC/BBV1602 and MIN/RYC1102). The CNIC is supported by the Ministry of Science, Innovation and Universities and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Bates, Georgina
  • Murphy, Michael P.
  • Almeida, Angeles
Cells naturally produce mitochondrial reactive oxygen species (mROS), but the in vivo pathophysiological significance has long remained controversial. Within the brain, astrocyte-derived mROS physiologically regulate behaviour and are produced at one order of magnitude faster than in neurons. However, whether neuronal mROS abundance differentially impacts on behaviour is unknown. To address this, we engineered genetically modified mice to down modulate mROS levels in neurons in vivo. Whilst no alterations in motor coordination were observed by down modulating mROS in neurons under healthy conditions, it prevented the motor discoordination caused by the pro-oxidant neurotoxin, 3-nitropropionic acid (3-NP). In contrast, abrogation of mROS in astrocytes showed no beneficial effect against the 3-NP insult. These data indicate that the impact of modifying mROS production on mouse behaviour critically depends on the specific cell-type where they are generated., J.P.B. is funded by the Agencia Estatal de Investigación (SAF2016-78114-R, PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), ISCIII (CB16/10/00282), Junta de Castilla y Le ́on (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundaci ́on BBVA and Fundaci ́on Ram ́on Areces. A.A. is funded by the ISCIII (PI18/00265, RD16/0019/0018), AEI (SAF2017-90794-REDT) and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009). J.P.B. and A.A. are funded by the grant CSI151P20 from the Junta de Castilla y Leon.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Opa1 relies on cristae preservation and ATP synthase to curtail reactive oxygen species accumulation in mitochondria

  • Quintana-Cabrera, Ruben
  • Manjarrés-Raza, Israel
  • Vicente-Gutiérrez, Carlos
  • Corrado, Mauro
  • Bolaños, Juan P.
  • Scorrano, Luca
Reactive oxygen species (ROS) are a common product of active mitochondrial respiration carried in mitochondrial cristae, but whether cristae shape influences ROS levels is unclear. Here we report that the mitochondrial fusion and cristae shape protein Opa1 requires mitochondrial ATP synthase oligomers to reduce ROS accumulation. In cells fueled with galactose to force ATP production by mitochondria, cristae are enlarged, ATP synthase oligomers destabilized, and ROS accumulate. Opa1 prevents both cristae remodeling and ROS generation, without impinging on levels of mitochondrial antioxidant defense enzymes that are unaffected by Opa1 overexpression. Genetic and pharmacologic experiments indicate that Opa1 requires ATP synthase oligomerization and activity to reduce ROS levels upon a blockage of the electron transport chain. Our results indicate that the converging effect of Opa1 and mitochondrial ATP synthase on mitochondrial ultrastructure regulate ROS abundance to sustain cell viability., R.Q.-C was supported by an AIRC and a Fondazione Veronesi fellowship and by a H2020 Marie Sklodowska-Curie IEF GA793987. J.P.B. is funded by Agencia Estatal de Investigación (PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018‐102576‐T), Instituto de Salud Carlos III (CB16/10/00282), Escalera de Excelencia CLU-2017-03, Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces. This work was supported by AIRC IG19991, Italian Ministry of Education, University and Research PRIN 2017BF3PXZ, Fondation Leducq TNE15004, Muscular Dystrophy Association (MDA USA) RG 603731 and Cariparo Foundation SIGMI (to L.S.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Astrocyte-neuron metabolic cooperation shapes brain activity

  • Bonvento, Gilles
  • Bolaños, Juan P.
The brain has almost no energy reserve, but its activity coordinates organismal function, a burden that requires precise coupling between neurotransmission and energy metabolism. Deciphering how the brain accomplishes this complex task is crucial to understand central facets of human physiology and disease mechanisms. Each type of neural cell displays a peculiar metabolic signature, forcing the intercellular exchange of metabolites that serve as both energy precursors and paracrine signals. The paradigm of this biological feature is the astrocyte-neuron couple, in which the glycolytic metabolism of astrocytes contrasts with the mitochondrial oxidative activity of neurons. Astrocytes generate abundant mitochondrial reactive oxygen species and shuttle to neurons glycolytically derived metabolites, such as L-lactate and L-serine, which sustain energy needs, conserve redox status, and modulate neurotransmitter-receptor activity. Conversely, early disruption of this metabolic cooperation may contribute to the initiation or progression of several neurological diseases, thus requiring innovative therapies to preserve brain energetics., G.B. received grants from the Centre National de la Recherche Scientifique (CNRS), the Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA), Agence Nationale de la Recherche (ANR 2011 MALZ-0003 MetALZ; ANR-18-C816-0008-03 ADORASTrAU), Association France Alzheimer, Fondation de France (Prix Spécial 2012), Fondation Alzheimer, and Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences (NeurATRIS ANR-11-INBS-0011). J.P.B. is funded by the Agencia Estatal de Investigación (PID2019-105699RB-I00 / AEI / 10.13039/501100011033 and RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), Junta de Castilla y León (CSI151P20 and Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA, and Fundación Ramón Areces.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis

  • López-Fabuel, Irene
  • García-Macia, Marina
  • Buondelmonte, Constantina
  • Burmistrova, Olga
  • Bonora, Nicoló
  • Alonso-Batán, Paula
  • Morant Ferrando, Brenda
  • Vicente-Gutiérrez, Carlos
  • Jimenez-Blasco, Daniel
  • Quintana-Cabrera, Ruben
  • Fernández, Emilio
  • Llop Roig, Jordi
  • Ramos-Cabrer, Pedro
  • Sharaireh, Aseel
  • Guevara-Ferrer, Marta
  • Fitzpatrick, Lorna M.
  • Thompton, Christopher D.
  • McKay, Tristan R.
  • Storch, Stephan
  • Medina, Diego L.
  • Mole, Sara E
  • Fedichev, Peter O.
  • Almeida, Angeles
  • Bolaños, Juan P.
CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. CLN7/MFSD8 gene encodes a lysosomal membrane glycoprotein, but the biochemical processes affected by CLN7-loss of function are unexplored thus preventing development of potential treatments. Here, we found, in the Cln7∆ex2 mouse model of CLN7 disease, that failure in autophagy causes accumulation of structurally and bioenergetically impaired neuronal mitochondria. In vivo genetic approach reveals elevated mitochondrial reactive oxygen species (mROS) in Cln7∆ex2 neurons that mediates glycolytic enzyme PFKFB3 activation and contributes to CLN7 pathogenesis. Mechanistically, mROS sustains a signaling cascade leading to protein stabilization of PFKFB3, normally unstable in healthy neurons. Administration of the highly selective PFKFB3 inhibitor AZ67 in Cln7∆ex2 mouse brain in vivo and in CLN7 patients-derived cells rectifies key disease hallmarks. Thus, aberrant upregulation of the glycolytic enzyme PFKFB3 in neurons may contribute to CLN7 pathogenesis and targeting PFKFB3 could alleviate this and other lysosomal storage diseases., This work was funded by the European Regional Development Fund, European Union’s Horizon 2020 Research and Innovation Programme (BATCure grant No. 666918 to J.P.B., S.E.M., D.L.M., S.S., and T.R.M.; PANA grant No. 686009 to A.A.), Agencia Estatal de Investigación (PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018‐102576‐T to J.P.B.; SAF2017-90794-REDT to A.A.), Instituto de Salud Carlos III (CB16/10/00282 to J.P.B.; PI18/00285; RD16/0019/0018 to A.A.), Junta de Castilla y León (CS/151P20 and Escalera de Excelencia CLU-2017-03 to J.P.B. and A.A.), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.), and Fundación Ramón Areces (to J.P.B. and A.A.). SM benefits from MRC funding to the MRC Laboratory for Molecular Cell Biology University Unit at UCL (award code MC_U12266B) towards lab and office space. Part of this work was funded by Gero Discovery L.L.C. M.G.M. is an ISCIII-Sara Borrel contract recipient (CD18/00203).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Amyloid-β Induces Cdh1-Mediated Rock2 Stabilization Causing Neurodegeneration

  • Lapresa, Rebeca
  • Agulla, Jesús
  • González-Guerrero, Sonia
  • Bolaños, Juan P.
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, which is causally related to the accumulation of abnormally folded amyloid-β (Aβ) peptide and hyperphosphorylated tau protein aggregates. The dendritic spine regulator Rho protein kinase 2 (Rock2) accumulates in the brain at the earliest stages of AD and remains increased during disease progression. However, the molecular mechanism that upregulates Rock2 in AD, and its role in the disease progression, are unknown. Here, we found that oligomers of the amyloidogenic fragment 25–35 of the Aβ peptide (Aβ25-35) trigger Rock2 accumulation and activation in mouse cortical neurons in primary culture and in mouse hippocampus in vivo. Neuronal apoptotic death and memory impairment caused by Aβ25-35 administration were rescued by genetic and pharmacological inhibition of Rock2 activity. Mechanistically, Aβ25-35 elicited cyclin dependent kinase-5 (Cdk5)-mediated phosphorylation of Cdh1, a cofactor that is essential for the activity of the E3 ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) in neurons. Notably, phosphorylated Cdh1 was disassembled from the APC/C complex, causing its inactivation and subsequent Rock2 protein stabilization and activation. Moreover, Aβ25-35-induced neuronal apoptosis was prevented by expressing a phosphodefective form of Cdh1, but not by a phosphomimetic Cdh1. Finally, Cdh1 inactivation, using both genetic and pharmacological approaches, enhanced Aβ25-35-mediated neuronal death through a mechanism that was prevented by inhibition of Rock2 activity. These results indicate that the Cdk5-Cdh1 signaling pathway accounts for the increased Rock2 activity by amyloidogenic Aβ peptides and that this mechanism may contribute to neurodegeneration and memory loss in AD., The work was funded by The Instituto de Salud Carlos III (to AA, PI21/00727 and RD21/0006/0005); European Regional Development Fund; European Union’s Horizon 2020 Research and Innovation Programme (to AA, grant agreement 686009); and Junta de Castilla y León (to AA and JB, CSI151P20 and CLU201703 P.O.FEDER CyL1420), and the Agencia Estatal de Investigación (to JB, PID 2019-105699RB-I00, MCIN/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR). RL, JA and SG-G are funded by Junta de Castilla y León (to RL and JA, CSI151P20; to SG-G, EDU/601/2020).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Metabolic Messengers: endocannabinoids

  • Busquets-Garcia, Arnau
  • Bolaños, Juan P.
  • Marsicano, Giovanni
Endocannabinoid signalling is considered one of the most important modulatory systems in a whole organism. Research has yielded great insight on the mechanisms that link endocannabinoids and metabolic functions. Here, we provide a brief overview of the metabolic roles of endocannabinoids in tissue, cellular and subcellular-dependent mechanisms. In general, we point out how the central and peripheral control of body energy metabolism likely represents the main function of type-1 cannabinoid receptors. More specifically, we focus on recent advances underlying mechanisms of endocannabinoid control of cell metabolism through the modulation of the functions of specific organelles. While highlighting a historical summary and summarizing past discoveries, this short review aims at proposing future open questions for a field that does not stop surprising researchers with unexpected and exciting discoveries., We also thank all the members of A.B.-G.’s, J.P.B.’s and G.M.’s labs for useful discussions and for their invaluable support. The work of A.B.-G. is supported by: Agencia Estatal de Investigación-FEDER (RTI2018-093667-A-100); the ERC starting Grant (HighMemory, #948217); the IBRO Return Home Fellowships 2019 and the Ramon y Cajal programme (RYC-2017-21776) funded by MCIN/ AEI/10.13039/501100011033 and FSE). The work of J.P.B. is funded by the Agencia Estatal de Investigación (PID2019-105699RB-I00; PDC2021-121013-I00; RED2018‐102576‐T; MCIN/AEI/10.13039/501100011033 & European Union NextGenerationEU/PRTR), Plan Nacional de Drogas (Ministerio de Sanidad; 2020I028) and Junta de Castilla y León (CS/151P20 and Escalera de Excelencia CLU-2017-03). The work of G.M. is funded by: INSERM, European Research Council (Endofood, ERC–2010–StG–260515 and CannaPreg, ERC-2014-PoC-640923, MiCaBra, ERC-2017-AdG-786467), Fondation pour la Recherche Medicale (FRM, DRM20101220445), the Human Frontiers Science Program, Region Nouvelle Aquitaine, Agence Nationale de la Recherche (ANR, NeuroNutriSens ANR-13-BSV4-0006 and ORUPS ANR-16-CE37-0010-01 and BRAIN ANR-10-LABX-0043).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

APC/C-Cdh1-targeted substrates as potential therapies for Alzheimer’s disease

  • Lapresa, Rebeca
  • Agulla, Jesús
  • Bolaños, Juan P.
  • Almeida, Angeles
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the main cause of dementia in the elderly. The disease has a high impact on individuals and their families and represents a growing public health and socio-economic burden. Despite this, there is no effective treatment options to cure or modify the disease progression, highlighting the need to identify new therapeutic targets. Synapse dysfunction and loss are early pathological features of Alzheimer’s disease, correlate with cognitive decline and proceed with neuronal death. In the last years, the E3 ubiquitin ligase anaphase promoting complex/cyclosome (APC/C) has emerged as a key regulator of synaptic plasticity and neuronal survival. To this end, the ligase binds Cdh1, its main activator in the brain. However, inactivation of the anaphase promoting complex/cyclosome-Cdh1 complex triggers dendrite disruption, synapse loss and neurodegeneration, leading to memory and learning impairment. Interestingly, oligomerized amyloid-β (Aβ) peptide, which is involved in Alzheimer’s disease onset and progression, induces Cdh1 phosphorylation leading to anaphase promoting complex/cyclosome-Cdh1 complex disassembly and inactivation. This causes the aberrant accumulation of several anaphase promoting complex/cyclosome-Cdh1 targets in the damaged areas of Alzheimer’s disease brains, including Rock2 and Cyclin B1. Here we review the function of anaphase promoting complex/cyclosome-Cdh1 dysregulation in the pathogenesis of Alzheimer’s disease, paying particular attention in the neurotoxicity induced by its molecular targets. Understanding the role of anaphase promoting complex/cyclosome-Cdh1-targeted substrates in Alzheimer’s disease may be useful in the development of new effective disease-modifying treatments for this neurological disorder., AA is funded by The Instituto de Salud Carlos III (PI21/00727, co-funded by the European Union). JB is funded by Agencia Estatal de Investigación (PID2019-105699RBI00). The Institute of Functional Biology and Genomics is funded by the Junta de Castilla y León (CLU-2017-03 co-funded by the P.O. FEDER CyL 14-20; CL-EI-2021-08, co-funded by the European Union ERDF). RL and JA are funded by Junta de Castilla y León (CSI151P20).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cross-talk between energy and redox metabolism in astrocyte-neuron functional cooperation

  • Almeida, Angeles
  • Jimenez-Blasco, Daniel
  • Bolaños, Juan P.
Astrocytes show unique anatomical, morphological, and metabolic features to take up substrates from the blood and metabolize them for local delivery to active synapses to sustain neuron function. In the present review, we specifically focus on key molecular aspects of energy and redox metabolism that facilitate this astrocyte-neuronal coupling in a controlled manner. Basal glycolysis is co-ordinated by the anaphase-promoting complex/cyclosome (APC/C)-Cdh1, a ubiquitin ligase that targets the proglycolytic enzyme 6-phosphofructokinase-2, 6-bisphosphastate-3 (PFKFB3) for degradation. APC/C-Cdh1 activity is more robust in neurons than in astrocytes, which determine that PFKFB3 abundance and glycolytic rate are weaker in neurons. The low PFKFB3 activity in neurons facilitates glucose-6-phosphate oxidation via the pentose-phosphate pathway, which promotes antioxidant protection. Conversely, the high PFKFB3 activity in astrocytes allows the production and release of glycolytic lactate, which is taken up by neurons that use it as an oxidizable substrate. Importantly, the mitochondrial respiratory chain is tighter assembled in neurons than in astrocytes, thus the bioenergetic efficiency of mitochondria is higher in neurons. Because of this, the production of reactive oxygen species (mROS) by mitochondrial complex I is very low in neurons and very high in astrocytes. Such a naturally occurring high abundance of mROS in astrocytes physiologically determines a specific transcriptional fingerprint that contributes to sustaining cognitive performance. We conclude that the energy and redox metabolism of astrocytes must complementarily match that of neurons to regulate brain function and animal welfare., This work was supported by the Agencia Estatal de Investigacion [grant numbers ´ PID2019-105699RB-I00/AEI/10.13039/501100011033, PDC2021-121013-I00, RED2018-102576-T (to J.P.B.)]; Plan Nacional de Drogas [grant number 2020I028 (to J.P.B.)]; Instituto de Salud Carlos III [grant numbers PI21/00727, RD21/0006/0005 cofunded by the European Union (to A.A.)]; and Junta de Castilla y Leon [grant number CS/151P20 cofunded by P.O. FEDER (to ´ A.A.)]; Apoyo Regional a la Competitividad Empresarial, [grant number ICE 04/18/LE/0017 (to J.P.B.)]; and Escalera de Excelencia [grant number CLU-2017-03 (to J.P.B. and A.A.)]. D.J.B. is a recipient of a Juan de la Cierva-Incorporacion contract [grant number ´ IJC2020-044230-I].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitochondrial sodium/calcium exchanger NCLX regulates glycolysis in astrocytes, impacting on cognitive performance

  • Cabral-Costa, João Victor
  • Vicente-Gutiérrez, Carlos
  • Agulla, Jesús
  • Lapresa, Rebeca
  • Elrod, John W.
  • Almeida, Angeles
  • Bolaños, Juan P.
  • Kowaltowski, Alicia J.
Intracellular Ca2+ concentrations are strictly controlled by plasma membrane transporters, the endoplasmic reticulum, and mitochondria, in which Ca2+ uptake is mediated by the mitochondrial calcium uniporter complex (MCUc), while efflux occurs mainly through the mitochondrial Na+/Ca2+ exchanger (NCLX). RNAseq database repository searches led us to identify the Nclx transcript as highly enriched in astrocytes when compared with neurons. To assess the role of NCLX in mouse primary culture astrocytes, we inhibited its function both pharmacologically or genetically. This resulted in re-shaping of cytosolic Ca2+ signaling and a metabolic shift that increased glycolytic flux and lactate secretion in a Ca2+-dependent manner. Interestingly, in vivo genetic deletion of NCLX in hippocampal astrocytes improved cognitive performance in behavioral tasks, whereas hippocampal neuron-specific deletion of NCLX impaired cognitive performance. These results unveil a role for NCLX as a novel modulator of astrocytic glucose metabolism, impacting on cognition., Agencia Estatal de Investigación, Grant/Award Number: PDC2021- 1 2 1 0 1 3 - I 0 0 , P I D 2 0 19 - 1 0 5 6 9 9 R B - I 0 0 /AEI/10.13039/501100011033 and RED2018-102576-T; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Grant/Award Number: line 001; Fundação de Amparo à Pesquisa do Estado de São Paulo, Grant/Award Number: #2013/07937-8, #2017/14713-0, #2019/22178-2 and #2020/06970-5; Instituto de Salud Carlos III, Grant/Award Number: PI21/00727 and RD21/0006/0005 co-funded by the European Union FED; Junta de Castilla y León, Grant/Award Number: Apoyo Regional a la Competitividad Empresarial, IC, CS/151P20 co-funded by P.O. FEDER and Escalera de Excelencia CLU-2017- 03; Plan Nacional de Drogas, Grant/Award Number: 2020I028, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Brightness and shadows of mitochondrial ROS in the brain

  • Jimenez-Blasco, Daniel
  • Almeida, Angeles
  • Bolaños, Juan P.
Mitochondrial reactive oxygen species (mROS) have been generally considered harmful byproducts wanted to clear when elevated to avoid brain damage. However, the abundance of mROS in astrocytes is very high -about one order of magnitude above that in neurons-, despite they are essential to preserve cell metabolism and animal behavior. Here, we have focused on this apparent ambiguity by discussing (i) the intrinsic mechanisms accounting for the higher production of mROS by the mitochondrial respiratory chain in astrocytes than in neurons, (ii) the specific molecular targets of astrocytic beneficial mROS, and (iii) how decreased astrocytic mROS causes excess neuronal mROS leading to cellular and organismal damage. We hope that this mini-review serves to clarifying the apparent controversy on the beneficial versus deleterious faces of ROS in the brain from molecular to higher-order organismal levels., Authors were supported by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PID2022-138813OB-I00; PDC2021–121013-I00; RED2018–102576-T to JPB; RED2022–134407-T to AA); Plan Nacional de Drogas (2020I028 to JPB); Instituto de Salud Carlos III (CB16/10/00282 to JPB; PI21/00727; PMP22/00084 and RD21/0006/0005 co-funded by the European Union, to AA); Marie Sklodowska-Curie Action HORIZON-MSCA-2021-DN-01 (101072759 to JPB and AAP), and Junta de Castilla y León (CS/151P20 co-funded by P.O. FEDER to AA; Apoyo Regional a la Competitividad Empresarial, ICE 04/18/LE/0017 to JPB, and Escalera de Excelencia CLU-2017-03 to JPB and AA). DJB is a recipient of a Juan de la Cierva-Incorporación contract (IJC2020–044230-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition

  • Morant Ferrando, Brenda
  • Jimenez-Blasco, Daniel
  • Alonso-Batán, Paula
  • Agulla, Jesús
  • Lapresa, Rebeca
  • Garcia-Rodriguez, Dario
  • Yunta-Sanchez, Sara
  • López-Fabuel, Irene
  • Fernández, Emilio
  • Carmeliet, Peter
  • Almeida, Angeles
  • García-Macia, Marina
  • Bolaños, Juan P.
Having direct access to brain vasculature, astrocytes can take up available blood nutrients and metabolize them to fulfil their own energy needs and deliver metabolic intermediates to local synapses. These glial cells should be, therefore, metabolically adaptable to swap different substrates. However, in vitro and in vivo studies consistently show that astrocytes are primarily glycolytic, suggesting glucose is their main metabolic precursor. Notably, transcriptomic data and in vitro studies reveal that mouse astrocytes are capable of mitochondrially oxidizing fatty acids and that they can detoxify excess neuronal-derived fatty acids in disease models. Still, the factual metabolic advantage of fatty acid use by astrocytes and its physiological impact on higher-order cerebral functions remain unknown. Here, we show that knockout of carnitine-palmitoyl transferase-1A (CPT1A)—a key enzyme of mitochondrial fatty acid oxidation—in adult mouse astrocytes causes cognitive impairment. Mechanistically, decreased fatty acid oxidation rewired astrocytic pyruvate metabolism to facilitate electron flux through a super-assembled mitochondrial respiratory chain, resulting in attenuation of reactive oxygen species formation. Thus, astrocytes naturally metabolize fatty acids to preserve the mitochondrial respiratory chain in an energetically inefficient disassembled conformation that secures signalling reactive oxygen species and sustains cognitive performance., We acknowledge the technical assistance of M. Resch, M. Carabias-Carrasco, L. Martin and E. Prieto-Garcia, from the University of Salamanca. This work was funded by the European Regional Development Fund, Agencia Estatal de Investigación (grant nos. PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018‐102576‐T to J.P.B. and SAF2017-90794-REDT to A.A.), Instituto de Salud Carlos III (grant nos. CB16/10/00282 to J.P.B. and PI18/00285 and RD16/0019/0018 to A.A.), Junta de Castilla y León (grant no. CS/151P20) and Escalera de Excelencia (grant no. CLU-2017-03 to J.P.B. and A.A.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

γ-Linolenic acid in maternal milk drives cardiac metabolic maturation

  • Paredes, Ana
  • Justo-Méndez, Raquel
  • Jimenez-Blasco, Daniel
  • Núñez, Vanessa
  • Calero, Irene
  • Villalba-Orero, María
  • Alegre-Martí, Andrea
  • Fischer, Thierry
  • Gradillas, Ana
  • Rodrigues Sant’Anna, Viviane Aparecida
  • Were, Felipe
  • Huang, Zhiqiang
  • Hernansanz-Agustín, Pablo
  • Contreras, Carmen
  • Martínez, Fernando
  • Camafeita, Emilio
  • Vázquez, Jesús
  • Ruiz-Cabello, Jesús
  • Area-Gomez, Estela
  • Sánchez-Cabo, Fátima
  • Treuter, Eckardt
  • Bolaños, Juan P.
  • Estébanez-Perpiñá, Eva
  • Rupérez, Francisco Javier
  • Barbas, Coral
  • Enríquez, José Antonio
  • Ricote, M. Mercedes
Birth presents a metabolic challenge to cardiomyocytes as they reshape fuel preference from glucose to fatty acids for postnatal energy production. This adaptation is triggered in part by post-partum environmental changes, but the molecules orchestrating cardiomyocyte maturation remain unknown. Here we show that this transition is coordinated by maternally supplied γ-linolenic acid (GLA), an 18:3 omega-6 fatty acid enriched in the maternal milk. GLA binds and activates retinoid X receptors (RXRs), ligand-regulated transcription factors that are expressed in cardiomyocytes from embryonic stages. Multifaceted genome-wide analysis revealed that the lack of RXR in embryonic cardiomyocytes caused an aberrant chromatin landscape that prevented the induction of an RXR-dependent gene expression signature controlling mitochondrial fatty acid homeostasis. The ensuing defective metabolic transition featured blunted mitochondrial lipid-derived energy production and enhanced glucose consumption, leading to perinatal cardiac dysfunction and death. Finally, GLA supplementation induced RXR-dependent expression of the mitochondrial fatty acid homeostasis signature in cardiomyocytes, both in vitro and in vivo. Thus, our study identifies the GLA–RXR axis as a key transcriptional regulatory mechanism underlying the maternal control of perinatal cardiac metabolism., The authors thank the members of the M.R. and J.A.E laboratories, A. Hidalgo and M. Torres for extensive discussions of the paper; G. Sabio, N. Rochel and D. Metzger for mice and reagents; CNIC and CRG Genomics Units for sequencing; S. Bartlett for editorial assistance; and A.V. Alonso, L. Flores, R. Baeza, R. Santos-Clemente, C. Gifford and N. Spann for technical assistance. J.P.B. is funded by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PDC2021-121013-I00, RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), and Junta de Castilla y León (Apoyo Regional a la Competitividad Empresarial, ICE 04/18/LE/0017 and Escalera de Excelencia CLU-2017-03). D.J.-B. And P.H.A. are recipients of a Juan de la Cierva-Incorporación contracts (IJC2020-044230-I and IJC2020-042679-I, respectively). F.J.R. is funded by the Ministerio de Ciencia e Innovación (MCIN) and European Regional Development Fund FEDER (PID2021- 122490NB-I00). V.A.R.S. received funding from Airbus Defense and Space through the CLX-2 programme in partnership with Comando da Aeronautica (COMAER) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES). E.T. received funding from the Swedish Research Council (2020-01150), the Swedish Cancer Society (211582), and the Novo Nordisk Foundation (NNF20OC0063672). J.A.E. was supported by RTI2018-099357-B-I00, MCIU/AEI/ ERDF/UE; RTI2018-099357-B-I00 MCIU/AEI; PID2021-1279880B-100 MCIN/AEI/ 10.13039/501100011033/ERDF,UE; CB16/10/00282 CIBERFES and 17CVD04 Foundation Leducq. This work was supported by grants to M.R.: SAF2017-90604-REDT-NurCaMeIn MINECO/AEI; RTI2018-095928-BI00, MCIU/AEI/ ERDF/UE; PID2021-122552OB-I00 MCIN/AEI/ 10.13039/501100011033/ERDF,UE; 201605-32 Fundació La Marató de TV3; and S2017/BMD- 3684 Comunidad de Madrid/ESF/EU, S2022/BMD-7227 Comunidad de Madrid; and an MINECO fellowship to A.P. (BES-2016-076632/AEI/ESF) and to R.J.-M. (PRE2019-087462). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/ AEI/ 10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A special issue in Essays in Biochemistry on astrocytes-more than a neuronal support network

  • Bolaños, Juan P.
Astrocytes are a type of non-neuronal, glial cells, anatomically placed in the intersection between the brain blood vessels and other neural cells-including neurons. Such a strategic situation confers these cells a unique opportunity to sense circulating molecules and adapt according to different organismal conditions. By acting as sentinel cells, astrocytes thus co-ordinate gene expression profiles, immune responses, signal transduction pathways, and metabolic programs that play essential roles in the formation of brain circuits to modulate neurotransmission and higher-order organismal functions., This work was funded by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (grant numbers 10.13039/501100011033, PID2019-105699RB-I00, PDC2021-121013-I00, RED2018‐102576‐T); Instituto de Salud Carlos III (grant number CB16/10/00282); and Junta de Castilla y León (grant numbers CS/151P20, Escalera de Excelencia CLU-2017-03)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice

  • Fernández-Moncada, Ignacio
  • Lavanco, Gianluca
  • Fundazuri, Unai B.
  • Bollmohr, Nasrin
  • Mountadem, Sarah
  • Dalla Tor, Tommaso
  • Hachaguer, Pauline
  • Julio-Kalajzic, Francisca
  • Gisquet, Doriane
  • Serrat, Roman
  • Bellocchio, Luigi
  • Cannich, Astrid
  • Fortunato-Marsol, Bérénice
  • Nasu, Yusuke
  • Campbell, Robert E.
  • Drago, Filippo
  • Cannizzaro, Carla
  • Ferreira, Guillaume
  • Bouzier-Sore, Anne-Karine
  • Pellerin, Luc
  • Bolaños, Juan P.
  • Bonvento, Gilles
  • Barros, L. Felipe
  • Oliet, Stephane H. R.
  • Panatier, Aude
  • Marsicano, Giovanni
Astrocytes control brain activity via both metabolic processes and gliotransmission, but the physiological links between these functions are scantly known. Here we show that endogenous activation of astrocyte type-1 cannabinoid (CB1) receptors determines a shift of glycolysis towards the lactate-dependent production of D-serine, thereby gating synaptic and cognitive functions in male mice. Mutant mice lacking the CB1 receptor gene in astrocytes (GFAP-CB1-KO) are impaired in novel object recognition (NOR) memory. This phenotype is rescued by the gliotransmitter D-serine, by its precursor L-serine, and also by lactate and 3,5-DHBA, an agonist of the lactate receptor HCAR1. Such lactate-dependent effect is abolished when the astrocyte-specific phosphorylated-pathway (PP), which diverts glycolysis towards L-serine synthesis, is blocked. Consistently, lactate and 3,5-DHBA promoted the co-agonist binding site occupancy of CA1 post-synaptic NMDA receptors in hippocampal slices in a PP-dependent manner. Thus, a tight cross-talk between astrocytic energy metabolism and gliotransmission determines synaptic and cognitive processes., The microscopy was done in the Bordeaux Imaging Center a service unit of the CNRS-INSERM and Bordeaux University, member of the national infrastructure France BioImaging supported by the French National Research Agency (ANR-10-INBS-04). We thank all past and present members of Marsicano’s lab for useful discussions and for their invaluable support. This study was funded by Inserm (to G.M., A.P. and S.H.R.O.); CNRS (to A.P. and S.H.R.O.); the European Research Council (Micabra, ERC-2017-AdG-786467, to G.M.); Fondation pour la Recherche Medicale (DRM20101220445, to G.M); EMBO Long-term Fellowship ALTF87-2018 (to I.F-M.); the Human Frontiers Science Program (to G.M.); Region Aquitaine (CanBrain, AAP2022A-2021-16763610 and −17219710 to A.-K.B.-S., L.P., A.P. and G.M.); French State/Agence Nationale de la Recherche (ERA-Net Neuron CanShank, ANR-21-NEU2-0001-04, to G.M), (CaMeLS, ANR-23-CE16-0022-01 to G.M., A.P. and G.B.), (Hippobese, ANR-23-CE14-0004-03, to G.F. and G.M.), (BrainFuel, ANR-21-CE44-0023-01 to A.-K.B.-S., L.P and AP.), (Excigly, ANR-20-CE16-0009-03 to S.H.R.O.), (Astrocom ANR-19-CE16-0015 to A.P.), (ANR-19-CE14-0039 to L.B.); the French government in the framework of the University of Bordeaux’s IdEx “Investments for the Future” program / GPR BRAIN_2030 / RRI IMPACT, the Japan Society for the Promotion of Science (21K14738, to Y.N. and 19H05633, to R.E.C.) and the Japan Science and Technology Agency (JPMJPR22E9, to Y.N.), Fondation Alzheimer (to G.B.), the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PID2022-138813OB-I00 and PDC2021-121013-I00 to J.P.B); European Commission action HORIZON-TMA-MSCA-DN (ETERNITY, 101072759, to J.P.B), La Caixa Research Health grant LCF/PR/HR23/52430016 (to J.P.B. and G.M.) and Fondecyt 1230145 & BMBF-ANID 180045 (to L.F.B.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Transcriptomic and metabolic signatures of neural cells cultured under a physiologic-like environment

  • Fernández, Emilio
  • Warde, Moussa
  • Manjarrés-Raza, Israel
  • Bobo-Jimenez, Veronica
  • Martinez-Luna, Maria
  • Vicente-Gutiérrez, Carlos
  • Garcia-Rodriguez, Dario
  • Jimenez-Blasco, Daniel
  • Almeida, Angeles
  • Bolaños, Juan P.
Cultured brain cells are used conventionally to investigate fundamental neurobiology and identify therapeutic targets against neural diseases. However, standard culture conditions do not simulate the natural cell microenvironment, thus hampering in vivo translational insight. Major weaknesses include atmospheric (21%) O2 tension and lack of intercellular communication, the two factors likely impacting metabolism and signaling. Here, we addressed this issue in mouse neurons and astrocytes in primary culture. We found that the signs of cellular and mitochondrial integrity were optimal when these cells were acclimated to grow in coculture, to emulate intercellular coupling, under physiologic (5%) O2 tension. Transcriptomic scrutiny, performed to elucidate the adaptive mechanism involved, revealed that the vast majority of differentially expressed transcripts were downregulated in both astrocytes and neurons. Gene ontology evaluation unveiled that the largest group of altered transcripts was glycolysis, which was experimentally validated by metabolic flux analyses. This protocol and database resource for neural cells grown under in vivo-like microenvironment may move forward the translation of basic into applied neurobiological research., The projects that gave rise to these results were funded by MICIU/AEI (PID2022–138813OB-I00, PID2019–105699RB-I00/10.13039/501100011033 and FEDER, UE to J. P. B.; SAF2017–90794-REDT to A. A.), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to J. P. B.), Instituto de Salud Carlos III (CB16/10/00282 to J. P. B.; PI21/00727, RD16/0019/0018, PMP22/00084 to A. A.), Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017–03 to J. P. B. and A. A.) and the European Union’s Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThE bRaiN In healtThY aging and age-related diseases, ETERNITY; to J. P. B. and A. A.). Estefanía Prieto-García was a recipient of a position by the Fondo Social Europeo, Youth Employment Initiative, Junta de Castilla y León., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Weak neuronal glycolysis sustains cognition and organismal fitness

  • Jimenez-Blasco, Daniel
  • Agulla, Jesús
  • Lapresa, Rebeca
  • García-Macia, Marina
  • Bobo-Jimenez, Veronica
  • Garcia-Rodriguez, Dario
  • Manjarres-Raza, Israel
  • Fernandez, Emilio
  • Jeanson, Yannick
  • Khoury, Spiro
  • Portais, Jean-Charles
  • Padro, Daniel
  • Ramos-Cabrer, Pedro
  • Carmeliet, Peter
  • Almeida, Angeles
  • Bolaños, Juan P.
The energy cost of neuronal activity is mainly sustained by glucose1,2. However, in an apparent paradox, neurons modestly metabolize glucose through glycolysis3-6, a circumstance that can be accounted for by the constant degradation of 6-phosphofructo-2-kinase-fructose-2,6-bisphosphatase-3 (PFKFB3)3,7,8, a key glycolysis-promoting enzyme. To evaluate the in vivo physiological importance of this hypoglycolytic metabolism, here we genetically engineered mice with their neurons transformed into active glycolytic cells through Pfkfb3 expression. In vivo molecular, biochemical and metabolic flux analyses of these neurons revealed an accumulation of anomalous mitochondria, complex I disassembly, bioenergetic deficiency and mitochondrial redox stress. Notably, glycolysis-mediated nicotinamide adenine dinucleotide (NAD+) reduction impaired sirtuin-dependent autophagy. Furthermore, these mice displayed cognitive decline and a metabolic syndrome that was mimicked by confining Pfkfb3 expression to hypothalamic neurons. Neuron-specific genetic ablation of mitochondrial redox stress or brain NAD+ restoration corrected these behavioural alterations. Thus, the weak glycolytic nature of neurons is required to sustain higher-order organismal functions., E. Prieto-García was a recipient of a position by the Fondo Social Europeo, Youth Employment Initiative, Junta de Castilla y León. Staff members (A. Rocher, H. Kulyk, N. Lager-Lachaud, L. Gales, F. Bellvert) of MetaToul (Toulouse, France, https://metatoul.fr) are gratefully acknowledged for technical support and access to MS facilities. The projects that gave rise to these results were funded by MICIU/AEI (PID2022-138813OB-I00, PID2019-105699RB-I00/10.13039/501100011033 and FEDER, UE to J.P.B.; SAF2017-90794-REDT to A.A.), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to J.P.B.), the Instituto de Salud Carlos III (CB16/10/00282 to J.P.B.; PI21/00727, RD16/0019/0018, PMP22/00084 to A.A.), the Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to J.P.B. and A.A.) and the European Union’s Horizon Europe research and innovation programme under MSCA Doctoral Networks 2021 (101072759, FuEl ThE bRaiN In healtThY aging and age-related diseases (ETERNITY), to J.P.B. and A.A.). MetaToul is part of the national infrastructure MetaboHUB and is funded by the French National Research Agency (ANR) with grant number MetaboHUB-ANR-11-INBS-0010., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Reprogramación metabólica en astrocitos por adquisición de mitocondrias exógenas

  • Yunta Sánchez, Sara
Trabajo presentado para lograr el título de Doctor por la Universidad de Salamanca, Programa de Doctorado en Biología Funcional y Genómica.--2025-07-04.--Calificación: Sobresaliente Cum Laude, La coordinación del estado metabólico en células neurales se establece a través de dinámicas de comunicación intercelular, donde la señalización mitocondrial emerge como un eje regulatorio fundamental. Así, la transferencia intercelular de estos orgánulos ha demostrado ser un evento fisio(pato)lógico en células neurales, con una especial relevancia en el Sistema Nervioso. Pese a los creciente avances en la caracterización estructural y funcional de la transferencia mitocondrial, su impacto sobre el remodelado metabólico en células receptoras y su correlato fisiológico en el mantenimiento metabólico del cerebro permanecen en gran parte inexplorados. Para abordar esta brecha de conocimiento, implementamos un modelo experimental in vitro que combina técnicas de trazado mitocondrial fluorescente con análisis metabólicos de alta eficiencia. Este diseño permitió estudiar la capacidad de transferencia mitocondrial entre células neurales y evaluar las consecuencias metabólicas de la adquisición de mitocondrias exógenas en astrocitos. Mediante dos enfoques - la interacción directa con neuronas primarias en co-cultivo, o la administración de mitocondrias aisladas de origen neural-, caracterizamos los posibles mecanismos de reconfiguración metabólica asociados a la internalización mitocondrial y, por ende, la función fisiológica de la transferencia mitocondrial. Los resultados obtenidos demuestran que la adquisición de mitocondrias neuronales por astrocitos induce un remodelado de la red mitocondrial y su morfología en las células receptoras. A nivel funcional, este proceso desencadena una reprogramación metabólica astrocítica mediada por mecanismos de señalización. Esta reconfiguración se manifiesta principalmente en un aumento de la ß-oxidación de ácidos grasos, acompañado de una estimulación de la cetogénesis y una activación astrocitaria hacia un fenotipo reactivo. Estos cambios se traducen en un aumento de liberación de cuerpos cetónicos al medio extracelular, y previsiblemente otros factores, que pueden ser captados por las neuronas para mejorar su respiración mitocondrial. Creemos que estos hallazgos aportan una valiosa información sobre cómo la transferencia mitocondrial opera como un sistema de señalización intercelular, que orquesta la cooperación metabólica astrocito-neurona. La internalización de mitocondrias neuronales por astrocitos activa rutas catabólicas generadoras de sustratos energéticos (cuerpos cetónicos) que son transferidos de vuelta a las neuronas, estableciendo un circuito de retroalimentación positiva. Las implicaciones de este estudio trascienden al ámbito básico, revelando que la plasticidad fenotípica de los astrocitos, tanto en su estado funcional como metabólico, puede ser modulado por señales mitocondriales exógenas. Esto abre perspectivas hasta ahora inexploradas en neurobiología y enfoques terapéuticos relacionados., Este trabajo ha sido financiado por la Agencia Estatal de Investigación (PID2019- 105699RB-I00; PID2022-138813OB-I00). Sara Yunta Sánchez obtuvo un contrato predoctoral de personal investigador de la Junta de Castilla y León cofinanciado con el Fondo Social Europeo (EDU/875/2021)., Peer reviewed